Skip to content
Back to Research Library
Fat Loss

AOD-9604 and Fat Metabolism: Current Research Findings

7 min readFebruary 20, 2026

What Is AOD-9604?

AOD-9604 (Anti-Obesity Drug 9604) is a modified 16-amino acid fragment of the C-terminus of human growth hormone (hGH), specifically the region spanning amino acids 177-191. This fragment was developed to isolate the fat-metabolizing activity of growth hormone without its growth-promoting or diabetogenic effects.

Mechanism of Action

AOD-9604 is believed to work through several pathways related to fat metabolism:

  • Lipolysis stimulation: AOD-9604 mimics the lipolytic action of natural growth hormone by stimulating the beta-3 adrenergic receptor pathway in adipose tissue.
  • Lipogenesis inhibition: Research suggests AOD-9604 may inhibit the transformation of non-fatty foods into body fat.
  • No IGF-1 elevation: Unlike full-length growth hormone, AOD-9604 does not stimulate IGF-1 production, which is responsible for many of GH's growth and proliferative effects.

Preclinical Evidence

Key research findings include:

  • Rodent studies: Obese mice treated with AOD-9604 showed significant reductions in body fat without changes in food consumption or lean body mass.
  • Receptor binding: Studies have confirmed AOD-9604 binds to the fat cell beta-3 adrenergic receptor with specificity, supporting its targeted mechanism.
  • Safety profile: Preclinical toxicology studies have shown a favorable safety profile, with no observed effects on blood glucose or tissue growth.
  • Dose-response: Research has demonstrated a clear dose-response relationship in fat reduction models.

Research Protocols

Researchers typically study AOD-9604 using the following approaches:

  • In vitro: Adipocyte cell cultures measuring lipolysis rates, receptor binding assays, and gene expression analysis.
  • In vivo: Rodent models of obesity measuring body composition changes, metabolic markers, and fat depot analysis.
  • Duration: Most preclinical studies span 2-4 weeks of daily administration.

Conclusion

AOD-9604 represents a targeted approach to studying growth hormone's fat-metabolizing properties in isolation. Its specificity for adipose tissue and lack of growth-promoting effects make it a useful research tool for understanding lipid metabolism pathways.